-
Mashup Score: 1Kayla's Krew - 9 month(s) ago
I’m excited to be participating in the 13th annual Closer to Free Ride on September 9th. I’ve signed up to support patient care and research at Smilow Cancer Hospital and Yale Cancer Center. 100% of the funds I raise go directly to changing and saving lives. Will you support me with a donation today?
Source: www.rideclosertofree.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5Support Nicholas Blondin - Swim Across the Sound 2023 - 10 month(s) ago
We are excited to join the 2023 Swim Across the Sound! This mission is very important to us and I’m proud to help make a difference. Please join us in supporting cancer patients by making a donation today. Large or small, all contributions are greatly appreciated. Thank you.
Source: charity.pledgeit.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Support Nicholas Blondin - Swim Across the Sound 2023 - 11 month(s) ago
We are excited to join the 2023 Swim Across the Sound! This mission is very important to us and I’m proud to help make a difference. Please join us in supporting cancer patients by making a donation today. Large or small, all contributions are greatly appreciated. Thank you.
Source: PledgeIt for CharitiesCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases - Full Text View - ClinicalTrials.gov - 12 month(s) ago
Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases – Full Text View.
Source: clinicaltrials.govCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0Smilow Shares: Brain Tumor Awareness Month - 1 year(s) ago
May 10, 2023Presentations from Drs. Jennifer Moliterno, Nicholas Blondin, and Mary Barden
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 02023 Path of Hope - 1 year(s) ago
Help support Connecticut Brain Tumor Alliance today!
Source: ctbta.rallybound.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2GBM AGILE | Overview | Global Coalition for Adaptive Research - 1 year(s) ago
GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) evaluates investigational therapies for patients with newly diagnosed and recurrent GBM – the deadliest brain cancer – and determines if any study treatment(s) improve overall survival as compared to standard treatments. An expert in developing and operationalizing adaptive platform trials and master protocols, Global…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
For patients with recurrent GBM, we found that a low dose regimen of BEV was associated with prolonged OS and PFS compared to the standard dose regimen. Lower dose schedules may be a better and more cost-effective option for patients with rGBM. Lower costs might provide more equitable access to this …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
AbstractBACKGROUND. Prospective data on maintenance therapy with bevacizumab for persons with NF2-related schwannomatosis (NF2-SWN) is lacking. In this prospect
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0BUD LIGHT HOLD | EASY TO DRINK, EASY TO ENJOY :60 - 1 year(s) ago
Take it from Miles Teller: even when you’re on hold, enjoyment is only a sip away. #EasyToEnjoy
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet
Super excited to be on #KaylasKrew for the Closer to Free ride next Saturday! The doctor is in!!! ♥️ #CTF2023 @YaleCancer @SmilowCancer #DefeatGBM https://t.co/xbEaW6DK3m